Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

1.

Therapeutic options for HER-2 positive breast cancer: Perspectives and future directions.

Recondo G, Dìaz Canton E, de la Vega M, Greco M, Recondo G, Valsecchi ME.

World J Clin Oncol. 2014 Aug 10;5(3):440-54. doi: 10.5306/wjco.v5.i3.440. Review.

PMID:
25114858
[PubMed]
Free PMC Article
2.

MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer.

Thirumurthi U, Shen J, Xia W, LaBaff AM, Wei Y, Li CW, Chang WC, Chen CH, Lin HK, Yu D, Hung MC.

Sci Signal. 2014 Jul 29;7(336):ra71. doi: 10.1126/scisignal.2005076.

PMID:
25074979
[PubMed - in process]
Free PMC Article
3.

Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models.

Formisano L, Nappi L, Rosa R, Marciano R, D'Amato C, D'Amato V, Damiano V, Raimondo L, Iommelli F, Scorziello A, Troncone G, Veneziani B, Parsons SJ, De Placido S, Bianco R.

Breast Cancer Res. 2014 May 5;16(3):R45. doi: 10.1186/bcr3650.

PMID:
24887236
[PubMed - in process]
Free PMC Article
4.

Cetuximab-induced MET activation acts as a novel resistance mechanism in colon cancer cells.

Song N, Liu S, Zhang J, Liu J, Xu L, Liu Y, Qu X.

Int J Mol Sci. 2014 Apr 4;15(4):5838-51. doi: 10.3390/ijms15045838.

PMID:
24714091
[PubMed - in process]
Free PMC Article
5.

DEspR roles in tumor vasculo-angiogenesis, invasiveness, CSC-survival and anoikis resistance: a 'common receptor coordinator' paradigm.

Herrera VL, Decano JL, Tan GA, Moran AM, Pasion KA, Matsubara Y, Ruiz-Opazo N.

PLoS One. 2014 Jan 21;9(1):e85821. doi: 10.1371/journal.pone.0085821. eCollection 2014.

PMID:
24465725
[PubMed - in process]
Free PMC Article
6.

Development of a chimeric c-Src kinase and HDAC inhibitor.

Ko KS, Steffey ME, Brandvold KR, Soellner MB.

ACS Med Chem Lett. 2013 Aug 8;4(8):779-783.

PMID:
24015327
[PubMed]
Free PMC Article
7.

Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.

Zhang XH, Jin X, Malladi S, Zou Y, Wen YH, Brogi E, Smid M, Foekens JA, Massagué J.

Cell. 2013 Aug 29;154(5):1060-73. doi: 10.1016/j.cell.2013.07.036.

PMID:
23993096
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

In vitro and in vivo models for analysis of resistance to anticancer molecular therapies.

Rosa R, Monteleone F, Zambrano N, Bianco R.

Curr Med Chem. 2014;21(14):1595-606.

PMID:
23992330
[PubMed - in process]
Free PMC Article
9.
10.

The relative expression of Mig6 and EGFR is associated with resistance to EGFR kinase inhibitors.

Chang X, Izumchenko E, Solis LM, Kim MS, Chatterjee A, Ling S, Monitto CL, Harari PM, Hidalgo M, Goodman SN, Wistuba II, Bedi A, Sidransky D.

PLoS One. 2013 Jul 31;8(7):e68966. doi: 10.1371/journal.pone.0068966. Print 2013.

PMID:
23935914
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

SRC family kinases as novel therapeutic targets to treat breast cancer brain metastases.

Zhang S, Huang WC, Zhang L, Zhang C, Lowery FJ, Ding Z, Guo H, Wang H, Huang S, Sahin AA, Aldape KD, Steeg PS, Yu D.

Cancer Res. 2013 Sep 15;73(18):5764-74. doi: 10.1158/0008-5472.CAN-12-1803. Epub 2013 Aug 1.

PMID:
23913825
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Active Component of Antrodia cinnamomea Mycelia Targeting Head and Neck Cancer Initiating Cells through Exaggerated Autophagic Cell Death.

Chang CW, Chen CC, Wu MJ, Chen YS, Chen CC, Sheu SJ, Lin TW, Chou SH, Lin SC, Liu CJ, Lee TC, Huang CY, Lo JF.

Evid Based Complement Alternat Med. 2013;2013:946451. doi: 10.1155/2013/946451. Epub 2013 Jun 12.

PMID:
23843890
[PubMed]
Free PMC Article
13.

Recent progress in mouse models for tumor suppressor genes and its implications in human cancer.

Inoue K, Fry EA, Taneja P.

Clin Med Insights Oncol. 2013 Jun 3;7:103-22. doi: 10.4137/CMO.S10358. Print 2013.

PMID:
23843721
[PubMed]
Free PMC Article
14.

Drugs for solid cancer: the productivity crisis prompts a rethink.

Rösel D, Brábek J, Veselý P, Fernandes M.

Onco Targets Ther. 2013 Jun 26;6:767-77. doi: 10.2147/OTT.S45177. Print 2013.

PMID:
23836990
[PubMed]
Free PMC Article
15.

Therapy's Shadow: A Short History of the Study of Resistance to Cancer Chemotherapy.

Keating P, Cambrosio A, Nelson NC, Mogoutov A, Cointet JP.

Front Pharmacol. 2013 May 7;4:58. doi: 10.3389/fphar.2013.00058. eCollection 2013.

PMID:
23675349
[PubMed]
Free PMC Article
16.

A network of substrates of the E3 ubiquitin ligases MDM2 and HUWE1 control apoptosis independently of p53.

Kurokawa M, Kim J, Geradts J, Matsuura K, Liu L, Ran X, Xia W, Ribar TJ, Henao R, Dewhirst MW, Kim WJ, Lucas JE, Wang S, Spector NL, Kornbluth S.

Sci Signal. 2013 May 7;6(274):ra32. doi: 10.1126/scisignal.2003741.

PMID:
23652204
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Targeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development.

Ma Y, Xiang D, Sun J, Ding C, Liu M, Hu X, Li G, Kloecker G, Zhang HG, Yan J.

J Immunol. 2013 Jun 1;190(11):5588-99. doi: 10.4049/jimmunol.1203216. Epub 2013 Apr 29.

PMID:
23630363
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Data-driven modeling of SRC control on the mitochondrial pathway of apoptosis: implication for anticancer therapy optimization.

Ballesta A, Lopez J, Popgeorgiev N, Gonzalo P, Doumic M, Gillet G.

PLoS Comput Biol. 2013 Apr;9(4):e1003011. doi: 10.1371/journal.pcbi.1003011. Epub 2013 Apr 4.

PMID:
23592961
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1.

Voena C, Di Giacomo F, Panizza E, D'Amico L, Boccalatte FE, Pellegrino E, Todaro M, Recupero D, Tabbò F, Ambrogio C, Martinengo C, Bonello L, Pulito R, Hamm J, Chiarle R, Cheng M, Ruggeri B, Medico E, Inghirami G.

Oncogenesis. 2013 Apr 8;2:e43. doi: 10.1038/oncsis.2013.7.

PMID:
23567620
[PubMed]
Free PMC Article
20.

67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis.

Kumazoe M, Sugihara K, Tsukamoto S, Huang Y, Tsurudome Y, Suzuki T, Suemasu Y, Ueda N, Yamashita S, Kim Y, Yamada K, Tachibana H.

J Clin Invest. 2013 Feb 1;123(2):787-99. doi: 10.1172/JCI64768. Epub 2013 Jan 25.

PMID:
23348740
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk